The alleged 'other company'25 Mar 2019 23:12
Knowlesi / scooby-doo,
You guys do not get whatever it is. The 'other company' is hemorrhaging money with no sign of cash generation other than through diluted placings. Their science is not as advanced as many private investors might think.
Hold, top-up, accumulate, deal in Q1, average down etc is not an advisable investment strategy on a biotech company with slow progress and little funds to continue the research. Are you not surprised that some who have some understanding of the 'other company' post on that bulletin board when people make claims that are seemingly divorced from reality.
Posting about the 'other company' does not deflect from the issues here - there may well be a placing here as well.
Personally, I will not invest in the 'other company' again unless there is a significant advance in their prospects that the market does not understand. I will certainly consider re-investing here once my concerns about financing are allayed but I would do so as part of my moon-shot funds - remember, mankind did manage to get to the moon.